The effects of age and liver disease on the disposition and elimination of diazepam in adult man.
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
This study investigates the separate effects of age and hepatocellular liver disease on the disposition and elimination of diazepam (Valium) in man. The drug was given either by rapid intravenous injection (0.1 mg/kg) or orally (10 mg) to 33 normal volunteers rnaging in age from 15 to 82 yr as well as to 9 individuals with alcoholic cirrhosis, 8 with acute viral hepatitis, and 4 with chronic active hepatitis. In the normal individuals, the terminal plasma half-life of diazepam, (t 1/2 (B)) exhibited a striking age-dependence; at 20 yr the t 1/2 (beta) was about 20 h, but it increased linearly with age to about 90 h at 80 yr. The plasma clearance of diazepam in the majority of the normal subjects was between 20 and 32 ml/min and showed no significant age-dependence. Cigarette smoking did not affect the half-life or the clearance. Additionally, neither the plasma binding (97.4 plus or minus 1.2%, mean plus or minus SD) nor the blood/plasma concentration ratio (0.58 plus or minus 0.16) of diazepam showed any age-related changes (P greater than 0.05). By contrast, analysis of the intravenous data according to a two-compartment open model indicated that both the initial distribution space (V1) and the volume of distribution at steady state [Vd(ss)] of diazepam increased linearly with age (P less than 0.005). The increase in Vd(ss) was secondary to the change in V1. It appears then that the prolongation of t 1/2 (beta) of diazepam with age is primarily dependent on an increase in the initial distribution volume of the drug. The plasma concentration/time course of the metabolite, desmethyldiazepam, was also affected by age. In older individuals, the initial presence and the peak values of desmethyldiazepam were observed later and the metabolite was present in lower concentrations. Despite the profound prolongation of t 1/2 (theta) with age, the constancy of diazepam clearance indicates that drug plasma concentrations will not accumulate any more in the old than the young, and chronic dosage more in the old than the young, and chronic dosage modifications based on pharmacokinetic considerations are unnecessary. Data obtained in patients with liver disease were compared with those found in age-matched control groups. Patients with cirrhosis showed a more than twofold prolongation in the half-life of diazepam (105.6 plus or minus 15.2 vs. 46.6 plus or minus 14.2 h, P less than 0.001).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clearance concepts in pharmacokinetics
Rowland, M., Benet, L. Z., & Graham, G. G. (1973) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059626 · Cited by 649
Lidocaine Pharmacokinetics in Advanced Heart Failure, Liver Disease, and Renal Failure in Humans
THOMSON, P. D., MELMON, K. L., RICHARDSON, J. A., COHN, K., STEINBRUNN, W., CUDIHEE, R., & ROWLAND, M. (1973) · Annals of Internal Medicine · doi:10.7326/0003-4819-78-4-499 · Cited by 512
Effect of Age and Sex on Human Drug Metabolism
O'MALLEY, K., Crooks, J., Duke, E., & Stevenson, I. H. (1971) · BMJ · doi:10.1136/bmj.3.5775.607 · Cited by 382
Determination of drug metabolizing enzymes in needle biopsies of human liver
Schoene, B., Fleischmann, R. A., Remmer, H., & v. Oldershausen, H. F. (1972) · European Journal of Clinical Pharmacology · doi:10.1007/bf00562499 · Cited by 328
Kaplan, S. A., Jack, M. L., Alexander, K., & Weinfeld, R. E. (1973) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600621111 · Cited by 260
RANDALL, L. O., Heise, G. A., Schallek, W., Bagdon, R. E., Banziger, R., Boris, A., MOE, R. A., & Abrams, W. B. (1961) · PubMed · Cited by 241
METABOLISM OF DIAZEPAM IN RAT, DOG, AND MAN
Schwartz, M. A., Koechlin, B. A., Postma, E., Palmer, S., & Krol, G. (1965) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27131-2 · Cited by 233
Evans, G. H., Nies, A. S., & Shand, D. G. (1973) · PubMed · Cited by 206
Blood Level Distribution Patterns of Diazepam and its Major Metabolite in Man
de Silva, J. A. F., Koechlin, B. A., & Bader, G. (1966) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600550706 · Cited by 200
the Boston Collaborative Drug Surveillance Program, B. U. M. C. (1973) · New England Journal of Medicine · doi:10.1056/nejm197302082880602 · Cited by 196
Cited by
Pharmacokinetics and drug metabolism in the elderly
Klotz, U. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902722679 · Cited by 826
“As body fat increases and total body water decreases, the apparent volume of distribution (Vd) of polar drugs (e.g., lithium, digoxin) will decrease (Hanratty et al., 2000) and that of lipophilic drugs (e.g., diazepam) will increase with advancing age (Klotz et al., 1975).”
BackgroundSelf-citationAdverse Sedation Events in Pediatrics: Analysis of Medications Used for Sedation
Coté, C. J., Karl, H. W., Notterman, D. A., Weinberg, J. A., & McCloskey, C. (2000) · Pediatrics · doi:10.1542/peds.106.4.633 · Cited by 616
Greenblatt (1982) · doi:10.1056/nejm198205063061804 · Cited by 584
Poulin, P., & Theil, F. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10005 · Cited by 568
Clinical Pharmacokinetics of Diazepam
Mandelli, M., Tognoni, G., & Garattini, S. (1978) · Clinical Pharmacokinetics · doi:10.2165/00003088-197803010-00005 · Cited by 496
Binding of Drugs to Serum Albumin
Koch-Weser, J., & Sellers, E. M. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602052940605 · Cited by 410
Age-Related Pharmacokinetic and Pharmacodynamic Changes and Related Risk of Adverse Drug Reactions
Corsonello, A., Pedone, C., & Incalzi, R. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416326 · Cited by 391
Diazepam disposition determinants
Greenblatt, D. J., Allen, M. D., Harmatz, J. S., & Shader, R. I. (1980) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1980.40 · Cited by 348
A Pharmacokinetic Standard for Babies and Adults
Holford, N., Heo, Y.-A., & Anderson, B. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23574 · Cited by 347
Delayed Clearance of Diazepam Due to Cimetidine
Klotz, U., & Reimann, I. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005013021807 · Cited by 337
Self-citationAdverse Drug Reactions Associated with Global Cognitive Impairment in Elderly Persons
LARSON, E. B., KUKULL, W. A., BUCHNER, D., & REIFLER, B. V. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-169 · Cited by 328
Prescribing for the Elderly Part I: Sensitivity of the Elderly to Adverse Drug Reactions*
Nolan, L., & O'Malley, K. (1988) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1988.tb01785.x · Cited by 327
Increased sensitivity to nitrazepam in old age
Castleden, C. M., George, C. F., Marcer, D., & Hallett, C. (1977) · BMJ · doi:10.1136/bmj.1.6052.10 · Cited by 320
Pharmacokinetics of Opioids in Liver Disease
Tegeder, I., L??tsch, J., & Geisslinger, G. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937010-00002 · Cited by 306
Postoperative Delirium in the Elderly
Parikh, S. S., & Chung, F. (1995) · Anesthesia & Analgesia · doi:10.1097/00000539-199506000-00027 · Cited by 300
The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates
Cotreau, M. M., von Moltke, L. L., & Greenblatt, D. J. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00002 · Cited by 292
Drug Use in the Elderly: A Review of Problems and Special Considerations
Vestal, R. E. (1978) · Drugs · doi:10.2165/00003495-197816040-00004 · Cited by 287
OUSLANDER, J. G. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-95-6-711 · Cited by 281
Protein Binding and Kinetics of Drugs in Liver Diseases
Blaschke, T. F. (1977) · Clinical Pharmacokinetics · doi:10.2165/00003088-197702010-00003 · Cited by 264
Age as a determinant of sensitivity to warfarin.
Shepherd, A., Hewick, D., Moreland, T., & Stevenson, I. (1977) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1977.tb00719.x · Cited by 262
Dose Adjustment in Patients with Liver Disease
Delc??, F., Tchambaz, L., Schlienger, R., Drewe, J., & Kr??henb??hl, S. (2005) · Drug Safety · doi:10.2165/00002018-200528060-00005 · Cited by 256
Smoking in Patients Receiving Psychotropic Medications: A Pharmacokinetic Perspective
Desai, H. D., Seabolt, J., & Jann, M. W. (2001) · CNS Drugs · doi:10.2165/00023210-200115060-00005 · Cited by 253
Pharmacokinetics in older persons
Cusack, B. J. (2004) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2004.12.005 · Cited by 253
The clinical implications of ageing for rational drug therapy
Shi, S., Mörike, K., & Klotz, U. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0422-1 · Cited by 244
“As a result, lipophilic drugs may have an increase in the apparent volume of distribution (V) with a prolonged halflife (t1⁄2), as has been seen, for example, with diazepam [123].”
BackgroundSelf-citationPetursson, H., & Lader, M. H. (1981) · British Journal of Addiction · doi:10.1111/j.1360-0443.1981.tb00218.x · Cited by 163
Implications of Altered Drug Disposition in the Elderly: Studies of Benzodiazepines
Greenblatt, D. J., Shader, R. I., & Harmatz, J. S. (1989) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1989.tb03246.x · Cited by 102
A review of the neuropsychological effects of commonly used prescription medications
Stein, R. A., & Strickland, T. L. (1998) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/13.3.259 · Cited by 98
Cantopher, T., Olivieri, S., Cleave, N., & Edwards, J. G. (1990) · British Journal of Psychiatry · doi:10.1192/bjp.156.3.406 · Cited by 67
Clinical Pharmacokinetics in Organ Transplant Patients
Venkataramanan, R., Habucky, K., Burckart, G. J., & Ptachcinski, R. J. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198916030-00002 · Cited by 67
Alprazolam in the elderly: pharmacokinetics and pharmacodynamics during multiple dosing
Kroboth, P. D., McAuley, J. W., & Smith, R. B. (1990) · Psychopharmacology · doi:10.1007/bf02243999 · Cited by 35
Data mining for potential adverse drug–drug interactions
Hammann, F., & Drewe, J. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.894507 · Cited by 19
“Age-related impairment of hepatic function may also influence metabolic activity and hence pharmacokinetics [23] .”
Background
Metadata
- Authors
- Klotz, U., Avant, G. R., Hoyumpa, A., Schenker, S., & Wilkinson, G. R.
- Venue
- Journal of Clinical Investigation
- Published
- 1975-02-01
- Volume
- 55
- Issue
- 2
- Pages
- 347-359
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2082425802
- Cited by
- 696
- References
- 25
- FWCI
- 38.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.